Skip to main content
OpenTrials

Clinical trial condition

Amyotrophic Lateral Sclerosis

Explore clinical trials studying Amyotrophic Lateral Sclerosis. Study availability and eligibility vary by location and protocol.

506 public trials 100 recruiting studies
Refine in advanced search Browse all conditions

Amyotrophic Lateral Sclerosis trial results

Recruiting

PREVENT ALL ALS Study

NCT06581861

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Irvine Orange, California, United States
View all 32 locations
View Trial Details
Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

NCT04363684

Conditions
Amyotrophic Lateral Sclerosis, Basal Ganglia Diseases, Behavioral Variant Frontotemporal Dementia (bvFTD), +41 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
View all 27 locations
View Trial Details
Recruiting

ASSESS ALL ALS Study

NCT06578195

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California, Irvine Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
View all 37 locations
View Trial Details
Recruiting

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

NCT07322003

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of South Florida Tampa, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Recruiting

A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis

NCT07571174

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • UZ Leuven Leuven, Belgium
  • University Hospital - London Health Sciences Centre London, Canada
  • McGill University Health Centre Montreal, Canada
  • Sunnybrook Research Institute Toronto, Canada
View Trial Details
Recruiting

A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT07571200

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • UZ Leuven Leuven, Belgium
  • University Hospital - London Health Sciences Centre London, Canada
  • McGill University Health Centre Montreal, Canada
  • Sunnybrook Research Institute Toronto, Canada
View Trial Details
Recruiting

A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)

NCT07290062

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • USA004 La Jolla, California, United States
  • USA002 Palo Alto, California, United States
  • USA001 Columbia, Missouri, United States
  • USA007 Columbus, Ohio, United States
View Trial Details

Related conditions